Hydrophilic Domain II of Escherichia coli Dr Fimbriae Facilitates Cell Invasion

ABSTRACT Uropathogenic and diarrheal Escherichia coli strains expressing adhesins of the Dr family bind to decay-accelerating factor, invade epithelial cells, preferentially infect children and pregnant women, and may be associated with chronic or recurrent infections. Thus far, no fimbrial domain(s) that facilitates cell invasion has been identified. We used alanine scanning mutagenesis to replace selected amino acids in hydrophilic domain II of the structural fimbrial subunit DraE and evaluated recombinant mutant DraE for attachment, invasion, and intracellular compartmentalization. The mutation of amino acids V28, T31, G33, Q34, T36, and P40 of DraE reduced or abolished HeLa cell invasion but did not affect attachment. Electron micrographs showed a stepwise entry and fusion of vacuoles containing Escherichia coli mutants T36A and Q34A or corresponding beads with lysosomes, whereas vacuoles with wild-type Dr adhesin showed no fusion. Mutants T31A and Q34A, which were deficient in invasion, appeared to display a reduced capacity for clustering decay-accelerating factor. Our findings suggest that hydrophilic domain II may be involved in cell entry. These data are consistent with the interpretation that in HeLa cells the binding and invasion phenotypes of Dr fimbriae may be separated.

[1]  Pietro Roversi,et al.  High Resolution Studies of the Afa/Dr Adhesin DraE and Its Interaction with Chloramphenicol* , 2004, Journal of Biological Chemistry.

[2]  Pietro Roversi,et al.  An atomic resolution model for assembly, architecture, and function of the Dr adhesins. , 2004, Molecular cell.

[3]  Bogdan Nowicki,et al.  Urinary tract infection in pregnant women: Old dogmas and current concepts regarding pathogenesis , 2002, Current infectious disease reports.

[4]  Mathura S Venkatarajan,et al.  Structure-Function Analysis of Decay-Accelerating Factor: Identification of Residues Important for Binding of the Escherichia coli Dr Adhesin and Complement Regulation , 2002, Infection and Immunity.

[5]  Betsy Foxman,et al.  Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. , 2002, The American journal of medicine.

[6]  E. Sokurenko,et al.  The Major Structural Subunits of Dr and F1845 Fimbriae Are Adhesins , 2002, Infection and Immunity.

[7]  S. Lea Interactions of CD55 with non-complement ligands. , 2001, Biochemical Society transactions.

[8]  R. Selvarangan,et al.  Rapid Receptor-Clustering Assay To Detect Uropathogenic and Diarrheal Escherichia coli Isolates Bearing Adhesins of the Dr Family , 2001, Journal of Clinical Microbiology.

[9]  S. Abraham,et al.  Glycosylphosphatidylinositol-anchored receptor-mediated bacterial endocytosis. , 2001, FEMS microbiology letters.

[10]  R. Selvarangan,et al.  Family of Escherichia coli Dr adhesins: decay-accelerating factor receptor recognition and invasiveness. , 2001, The Journal of infectious diseases.

[11]  B. Finlay,et al.  Microbial pathogenesis: Lipid rafts as pathogen portals , 2000, Current Biology.

[12]  J. Nataro,et al.  Characterization of the AfaD‐like family of invasins encoded by pathogenic Escherichia coli associated with intestinal and extra‐intestinal infections , 2000, FEBS letters.

[13]  R. Selvarangan,et al.  Role of Decay-Accelerating Factor Domains and Anchorage in Internalization of Dr-Fimbriated Escherichia coli , 2000, Infection and Immunity.

[14]  E. Johnsson,et al.  Human complement regulators: a major target for pathogenic microorganisms. , 2000, Current opinion in immunology.

[15]  R. Powell,et al.  Crystallization and preliminary X-ray diffraction analysis of a biologically active fragment of CD55. , 1999, Acta crystallographica. Section D, Biological crystallography.

[16]  S. Schappert,et al.  Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1997. , 1997, Vital and health statistics. Series 13, Data from the National Health Survey.

[17]  D. Shafren Viral Cell Entry Induced by Cross-Linked Decay-Accelerating Factor , 1998, Journal of Virology.

[18]  B. Nowicki,et al.  Molecular cloning and characterization of Dr-II, a nonfimbrial adhesin-I-like adhesin isolated from gestational pyelonephritis-associated Escherichia coli that binds to decay-accelerating factor , 1997, Infection and immunity.

[19]  A. Labigne,et al.  Adhesion to and invasion of HeLa cells by pathogenic Escherichia coli carrying the afa-3 gene cluster are mediated by the AfaE and AfaD proteins, respectively , 1997, Infection and immunity.

[20]  R. Selvarangan,et al.  Dr fimbriae operon of uropathogenic Escherichia coli mediate microtubule-dependent invasion to the HeLa epithelial cell line. , 1997, The Journal of infectious diseases.

[21]  N. Hibler,et al.  Arrest of Mycobacterial Phagosome Maturation Is Caused by a Block in Vesicle Fusion between Stages Controlled by rab5 and rab7* , 1997, The Journal of Biological Chemistry.

[22]  L. Truong,et al.  Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis. , 1997, The Journal of clinical investigation.

[23]  S. Moseley,et al.  Mutational analysis of receptor binding mediated by the Dr family of Escherichia coli adhesins , 1997, Molecular microbiology.

[24]  C. Bloch,et al.  Virulence characteristics of Escherichia coli causing first urinary tract infection predict risk of second infection. , 1995, The Journal of infectious diseases.

[25]  J. Bergelson,et al.  Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[26]  B. Nowicki,et al.  Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction , 1993, The Journal of experimental medicine.

[27]  A. Miettinen,et al.  Binding of bacterial adhesins to rat glomerular mesangium in vivo. , 1993, Kidney international.

[28]  S. Moseley,et al.  Molecular structure of the Dr adhesin: nucleotide sequence and mapping of receptor-binding domain by use of fusion constructs , 1991, Infection and immunity.

[29]  Richard,et al.  The Dr hemagglutinin, afimbrial adhesins AFA-I and AFA-III, and F1845 fimbriae of uropathogenic and diarrhea-associated Escherichia coli belong to a family of hemagglutinins with Dr receptor recognition , 1990, Infection and Immunity.

[30]  B. Nowicki,et al.  A hemagglutinin of uropathogenic Escherichia coli recognizes the Dr blood group antigen , 1988, Infection and immunity.

[31]  L. Truong,et al.  Presence of the Dr receptor in normal human tissues and its possible role in the pathogenesis of ascending urinary tract infection. , 1988, The American journal of pathology.

[32]  B. Nowicki,et al.  Molecular cloning of the Escherichia coli O75X adhesin , 1987, Infection and immunity.

[33]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.